SPYRE THERAPEUTICS, INC. Realized Gains on Marketable Securities
SPYRE THERAPEUTICS, INC. (SYRE) reported Realized Gains on Marketable Securities of $0 for the 9-month period ending 2019-09-30, per its 10-Q filed 2019-11-06.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesRealizedGainLoss · last filed 2020-02-24
- SPYRE THERAPEUTICS, INC. marketable securities, realized gain (loss) for the quarter ending 2019-09-30 was $0.00.
- SPYRE THERAPEUTICS, INC. marketable securities, realized gain (loss) for the quarter ending 2019-06-30 was $0.00.
- SPYRE THERAPEUTICS, INC. marketable securities, realized gain (loss) for the quarter ending 2019-03-31 was $0.00.
- SPYRE THERAPEUTICS, INC. marketable securities, realized gain (loss) for the quarter ending 2018-12-31 was $0.00.
- SPYRE THERAPEUTICS, INC. marketable securities, realized gain (loss) for fiscal 2018 was $0.00.
- SPYRE THERAPEUTICS, INC. marketable securities, realized gain (loss) for fiscal 2017 was $0.00.
- SPYRE THERAPEUTICS, INC. marketable securities, realized gain (loss) for fiscal 2016 was $0.00.
- SPYRE THERAPEUTICS, INC. marketable securities, realized gain (loss) for fiscal 2015 was $0.00.
| Period end | Marketable Securities, Realized Gain (Loss) 3 month | Marketable Securities, Realized Gain (Loss) 6 month | Marketable Securities, Realized Gain (Loss) 9 month | Marketable Securities, Realized Gain (Loss) 12 month |
|---|---|---|---|---|
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $0.00 10-Q · filed 2019-11-06 | $0.00 derived: sum of 4 quarters · filed 2020-02-24 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $0.00 10-Q · filed 2019-08-06 | $0.00 derived: sum of 3 quarters · filed 2020-02-24 | $0.00 derived: sum of 4 quarters · filed 2020-02-24 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-07 | $0.00 derived: sum of 2 quarters · filed 2020-02-24 | $0.00 derived: sum of 3 quarters · filed 2020-02-24 | $0.00 derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $0.00 derived: sum of 2 quarters · filed 2020-02-24 | $0.00 derived: sum of 3 quarters · filed 2020-02-24 | $0.00 10-K · filed 2020-02-24 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $0.00 derived: sum of 2 quarters · filed 2019-11-06 | $0.00 10-Q · filed 2019-11-06 | $0.00 derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $0.00 10-Q · filed 2019-08-06 | $0.00 derived: sum of 3 quarters · filed 2020-02-24 | $0.00 derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $0.00 10-Q · filed 2019-05-07 | $0.00 derived: sum of 2 quarters · filed 2020-02-24 | $0.00 derived: sum of 3 quarters · filed 2020-02-24 | $0.00 derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $0.00 derived: sum of 2 quarters · filed 2020-02-24 | $0.00 derived: sum of 3 quarters · filed 2020-02-24 | $0.00 10-K · filed 2020-02-24 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $0.00 derived: sum of 2 quarters · filed 2018-11-08 | $0.00 10-Q · filed 2018-11-08 | $0.00 derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-09 | $0.00 10-Q · filed 2018-08-09 | $0.00 derived: sum of 3 quarters · filed 2019-03-07 | $0.00 derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | $0.00 10-Q · filed 2018-05-08 | $0.00 derived: sum of 2 quarters · filed 2019-03-07 | $0.00 derived: sum of 3 quarters · filed 2019-03-07 | $0.00 derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | $0.00 derived: sum of 2 quarters · filed 2019-03-07 | $0.00 derived: sum of 3 quarters · filed 2019-03-07 | $0.00 10-K · filed 2019-03-07 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $0.00 derived: sum of 2 quarters · filed 2016-11-09 | $0.00 10-Q · filed 2016-11-09 | $0.00 derived: sum of 4 quarters · filed 2018-03-13 |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $0.00 10-Q · filed 2016-08-09 | $0.00 derived: sum of 3 quarters · filed 2018-03-13 | $0.00 derived: sum of 4 quarters · filed 2018-03-13 |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-09 | $0.00 derived: sum of 2 quarters · filed 2018-03-13 | $0.00 derived: sum of 3 quarters · filed 2018-03-13 | $0.00 derived: sum of 4 quarters · filed 2018-03-13 |
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $0.00 derived: sum of 2 quarters · filed 2018-03-13 | $0.00 derived: sum of 3 quarters · filed 2018-03-13 | $0.00 10-K · filed 2018-03-13 |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $0.00 derived: sum of 2 quarters · filed 2016-11-09 | $0.00 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $0.00 10-Q · filed 2016-08-09 | ||
| 2015-03-31 | $0.00 10-Q · filed 2016-05-19 | |||
| 2014-12-31 | $0.00 10-K · filed 2017-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |